Keyphrases
Laparoscopic Distal Pancreatectomy
100%
Cost-effectiveness
100%
Robotics
100%
Pathological Complete Response
100%
Risk Factors
100%
Distant Recurrence
100%
Neoadjuvant Therapy
100%
Locally Advanced Rectal Cancer
100%
Long-term Oncological Outcomes
100%
Overall Survival
50%
Distant Metastasis-free Survival
50%
Oncologic
50%
Distant Metastasis
33%
Colorectal Cancer
33%
Euro
16%
CEA Levels
16%
Abdominoperineal Excision
16%
Retrospective multicenter Study
16%
Independent Risk Factors
16%
Oncological Outcomes
16%
Combined Modality Therapy
16%
Overall Survival Rate
16%
ASA III
16%
Neoadjuvant Chemoradiotherapy (nCRT)
16%
Regression Analysis
16%
Metachronous
16%
Surrogate Marker
16%
Tumor Cells
16%
Projected Database
16%
Survival Rate
16%
Robotic Approach
11%
Health Systems
5%
Comprehensive Complication Index
5%
Operative Time
5%
Laparoscopy
5%
Operative Costs
5%
Splenectomy
5%
Conversion Rate
5%
Willingness-to-pay Threshold
5%
Clinical Data
5%
After Surgery
5%
Consecutive Patients
5%
Minimally Invasive Distal Pancreatectomy
5%
Cost Data
5%
Overall Cost
5%
Medicine and Dentistry
Overall Survival
100%
Rectum Cancer
100%
Neoadjuvant Therapy
100%
Recurrent Disease
100%
Cost-Effectiveness Analysis
100%
Distal Pancreatectomy
100%
Distant Metastasis Free Survival
75%
Distant Metastasis
50%
Survival Rate
50%
Health Care Cost
26%
Chemoradiotherapy
25%
Carcinoembryonic Antigen
25%
Disease Marker
25%
Tumor Cell
25%
Acetylsalicylic Acid
25%
Quality Adjusted Life Year
10%
Laparoscopic Surgery
5%
Prospective Study
5%
Operation Duration
5%
Splenectomy
5%
